We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
VR effect on perceived pain
Timeframe: Baseline to end of intervention (4 weeks)
VR effect on perceived fatigue
Timeframe: Baseline to end of intervention (4 weeks)
VR effect on perceived anxiety
Timeframe: Baseline to end of intervention (4 weeks)
Audio effect on perceived pain
Timeframe: Baseline to end of intervention (4 weeks)
Audio effect on perceived fatigue
Timeframe: Baseline to end of intervention (4 weeks)
Audio effect on perceived anxiety
Timeframe: Baseline to end of intervention (4 weeks)
Difference in effect of VR vs audio MP4 intervention on pain
Timeframe: Baseline to end of intervention (4 weeks)
Difference in effect of VR vs audio MP4 intervention on fatigue
Timeframe: Baseline to end of intervention (4 weeks)
Difference in effect of VR vs audio MP4 intervention on anxiety
Timeframe: Baseline to end of intervention (4 weeks)
VR effect on perceived depression
Timeframe: Baseline to end of intervention (4 weeks)
Audio effect on perceived depression
Timeframe: Baseline to end of intervention (4 weeks)
Difference in effect of VR vs audio MP4 intervention on depression
Timeframe: Baseline to end of intervention (4 weeks)